Select Medical Holdings Declares $0.0625 Quarterly Dividend
Select Medical Holdings Corporation (NYSE: SEM), a provider of healthcare services, announced a quarterly cash dividend of $0.0625 per share. The dividend will be paid March 12, 2026.
Select Medical Holdings Corporation (NYSE: SEM), a provider of healthcare services including rehabilitation hospitals and outpatient facilities, declared a quarterly cash dividend of $0.0625 per share on February 12, 2026. The dividend will be paid to shareholders of record as of March 2, 2026. Read more dividend announcements.
The company's board approved the distribution, which will be paid on or about March 12, 2026. Select Medical noted that future dividend declarations remain at the discretion of the board and will depend on the company's financial condition, operating results, available cash, debt obligations, and other relevant factors.
| Dividend Details | Date |
|---|---|
| Amount per Share | $0.0625 |
| Record Date | March 2, 2026 |
| Payment Date | March 12, 2026 |
| Declaration Date | February 12, 2026 |
Fourth Quarter and Full Year Results
The dividend announcement coincided with Select Medical's release of fourth quarter and full year 2025 financial results. Revenue for the fourth quarter ended December 31, 2025 increased 6.4% to $1,396.6 million, compared to $1,312 million in the same period a year earlier.
The company's outpatient rehabilitation segment generated revenue of $324.6 million in the fourth quarter, up 1.6% from $319.6 million in the prior-year quarter. Adjusted EBITDA for this segment declined to $11.2 million from $26.6 million, with the margin falling to 3.4% from 8.3%.
For the full year 2025, outpatient rehabilitation revenue rose 2.8% to $1,284.9 million from $1,250.3 million. Adjusted EBITDA for the segment was $90.2 million, down from $108.6 million in 2024, with the margin compressing to 7.0% from 8.7%.
Share Repurchase Program
Select Medical's board has authorized a stock repurchase program to buy back up to $1.0 billion worth of common stock through December 31, 2027. During 2025, the company repurchased 6,375,512 shares at a total cost of approximately $96.5 million, or $15.13 per share including transaction costs.
The company funds the repurchase program through cash on hand and borrowings under its revolving credit facility. Repurchases may be made in the open market or through privately negotiated transactions at the company's discretion.